NCT05309226View on ClinicalTrials.gov

Cannabis Use in Pregnancy and Downstream Effects on Maternal and Infant Health

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

January 7, 2025

Study Completion Date

February 1, 2025

Conditions
Cannabis UseMarijuana Use
Interventions
OTHER

Cannabis use in pregnancy or cannabis exposure in utero

Cannabis-related product use in pregnancy. Cannabis-related products will include all forms (e.g., dry flower, edibles, extracts, etc.) and formats of consumption (e.g., joint, bong, capsule, tincture, etc.).

Trial Locations (4)

K7L 2V7

Kingston Health Sciences Centre, Kingston

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

K1H 8L6

The Ottawa Hospital - Civic Campus, Ottawa

The Ottawa Hospital - General Campus, Ottawa

Sponsors
All Listed Sponsors
collaborator

Kingston Health Sciences Centre

OTHER

collaborator

Children's Hospital of Eastern Ontario Research Institute

OTHER

lead

Ottawa Hospital Research Institute

OTHER